Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2005
09/28/2005EP1578725A1 Microsomal triglyceride transfer protein inhibitors
09/28/2005EP1578717A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
09/28/2005EP1578716A1 Dicarboxylic acid derivatives as ppar-agonists
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1341534A4 Compounds having fungicidal activity and processes to make and use same
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005CN1675322A Printing process using specified azo compounds
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675165A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674784A Novel 2-pyridylethylbenzamide derivative
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220682C Heterocycle derivatives inhibiting factor Xa
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949573 Substituted 3-amidopyridine derivatives are useful for treating inflammatory, allergic and respiratory diseases, as well as wounds
09/27/2005US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
09/27/2005CA2122346C Bistriazenes as chemotherapeutic agents
09/22/2005WO2005087741A1 PHOTOCHARGE SEPARATION USING SUPRAMOLECULAR COMPLEX OF π-ELECTRON TYPE EXTENDED VIOLOGEN DERIVATIVE AND PORPHYRIN
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005087211A1 Anti-parasitic compounds and methods of their use
09/22/2005WO2005072681A3 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
09/22/2005WO2005037208A3 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
09/22/2005WO2004112480A3 Triazolopyrimidines
09/22/2005US20050209472 Preparation of metal amide complexes
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209461 Process for conversion of cyanopyridines to nicotinamides and catalyst therefor, process for preparing said catalyst
09/22/2005US20050209460 Process for the preparation of torsemide and related intermediates
09/22/2005US20050209458 Consisting of silicotungstic acid, phosphotungstic acid, phosphomolybdic acid on a support; pesticides; reacting acetaldehyde and ammonia under heat to form 2- and 4-picolines
09/22/2005US20050209457 Process for the production of pyridine and picolines
09/22/2005US20050209420 Catalyst composition and use thereof
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209221 Pyrimidine or pyridine carboxamides or pharmaceutically-acceptable salts thereof, for example, 1,1-dimethylethyl 4-(4-((5-(((2,6-dimethylphenyl)amino)carbonyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)-1-piperazinecarboxylate; for protein tyrosine kinase-associated disorders
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005DE10100772B4 Ether- und Amidverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidiabetika Ether and amide compounds, processes for their preparation and their use as antidiabetic agents
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2557904A1 Hiv integrase inhibitors
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1577301A1 Diamine derivatives
09/21/2005EP1577300A1 Platinum complexes
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575951A1 Heterocyclic compounds, methods of making them and their use in therapy
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575921A1 Process for the synthesis of isonicotinic acid hydrazide
09/21/2005EP1575920A1 Process for conversion of cyanopyridines to nicotinamides and catalyst therefor, process for preparing said catalyst
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575918A2 Substituted biaryl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575901A2 Substituted amides
09/21/2005EP1575586A1 2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1438038A4 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005CN1672094A Electrolytes for electrooptic devices comprising ionic liquids
09/21/2005CN1671819A Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671665A Process for producing 5-(2 -pyridyl)-2-pyridone derivative
09/21/2005CN1671654A Gelling agents
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671644A Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219767C Process for preparing nicotinic acid
09/21/2005CN1219766C Pyridyl tetraquinone molecular material and its preparing process
09/21/2005CN1219765C Pyridine chloridizing process of producing mixture of pyridine tetrachloride and pyridine pentachloride
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/20/2005US6946688 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946569 high stereoselectivity; mannitol and tartaric acid starting materials, hydrogenation of ketones, imines, and olefins; 1,2((2,2',5,5'-tetramethyl, 3,3',4,4'-tetrahydroxy) bisphospholane)benzene.
09/20/2005US6946568 Titanium, zirconium, hafnium, vandium, niobium or tantalum complexed with an imine and an amine, oxy or sulfide
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946559 Method of converting functional group through halogen-metal exchange reaction
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 633